Vanguard Global Advisers’s Day One Biopharmaceuticals DAWN Stock Holding History

Vanguard Global Advisers’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-29,783	Closed	-$639K	–	3671
2026 Q1	$639K	Buy	+29,783	New	+$420K	﹤0.01%	1924

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Vanguard Global Advisers's DAWN Position: Q2 2026 in Review

Vanguard Global Advisers sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 29,783 shares — an estimated $639K sold.

Vanguard Global Advisers first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $639K in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Vanguard Global Advisers reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Vanguard Global Advisers sold 29,783 Day One Biopharmaceuticals shares in Q2 2026, an estimated $639K.
Vanguard Global Advisers first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
Vanguard Global Advisers's Day One Biopharmaceuticals position peaked at $639K in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.